Sign Up Today and Learn More About VitriVax Stock
Invest in or calculate the value of your shares in VitriVax or other pre-IPO companies through EquityZen's platform.
VitriVax Stock
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
About VitriVax Stock
Founded
2017
Headquarters
Boulder, CO, US
Industries
Software, Artificial Intelligence, Data and Analytics
VitriVax Press Mentions
Stay in the know about the latest news on VitriVax
VitriVax raises $17.25M in Series B funding round
bizwest • Oct 25, 2025
VitriVax Secures $17.25M in Series B Funding for Advanced Vaccine Technology
venturecapital • Oct 24, 2025
VitriVax Raises $17.25 Million Series B Financing
vcnewsdaily • Oct 23, 2025
VitriVax Raises $17.25 Million Series B Financing to Advance Vaccine Formulation Platform
vcaonline • Oct 23, 2025
VitriVax Awarded $9.9M Grant to Enable Scaling up of Clinical Manufacturing
biospace • Oct 15, 2025
VitriVax Management
Leadership team at VitriVax
Co-founder and CTO
Theodore Randolph
Co-Founder and CSO
Robert Garcea
Join now and verify your accreditation status to gain access to:
- VitriVax Current Valuation
- VitriVax Stock Price
- VitriVax Management
- Available deals in VitriVax and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- VitriVax Cap Table and Funding History by Share Class and Liquidity Preferences
- VitriVax Revenue and Financials
- VitriVax Highlights
- VitriVax Business Model
- VitriVax Risk Factors
- VitriVax Research Report from SACRA Research
Trading VitriVax Stock
How to invest in VitriVax stock?
Accredited investors can buy pre-IPO stock in companies like VitriVax through EquityZen funds. These investments are made available by existing VitriVax shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell VitriVax stock?
Shareholders can sell their VitriVax stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."